Acasă › Leucemie mieloasă acută › California › San Francisco
Studii clinice pentru Leucemie mieloasă acută în San Francisco, CA
12 studii pentru Leucemie mieloasă acută caută participanți în și în jurul orașului San Francisco (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
În curs de recrutareFaza 2
- Kaiser Permanente-San Francisco, San Francisco
- UCSF Medical Center-Parnassus, San Francisco
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
În curs de recrutareFaza 2
- UCSF Medical Center-Parnassus, San Francisco
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
În curs de recrutareFaza 2
- UCSF Medical Center-Parnassus, San Francisco
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
În curs de recrutareFaza 2
- UCSF Medical Center-Parnassus, San Francisco
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
În curs de recrutareFaza 2
- Kaiser Permanente-San Francisco, San Francisco
- UCSF Medical Center-Parnassus, San Francisco
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
În curs de recrutareFaza 3
- UCSF Medical Center-Mission Bay, San Francisco
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
În curs de recrutareFaza 3
- US-San Francisco CA-UCSF, San Francisco
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
În curs de recrutareFaza 3
- US-San Francisco CA-UCSF, San Francisco
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
În curs de recrutareFaza 1/2
- UCSF Medical Center-Mission Bay, San Francisco
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
În curs de recrutareFaza 3
- Benioff Children's Hospital - Mission Bay, San Francisco
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
În curs de recrutareFaza 1
- University of California San Francisco, San Francisco
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
În curs de recrutareStudiu observațional
- UCSF (Peds), San Francisco
Studii pentru Leucemie mieloasă acută în alte orașe
- Houston, TX85 studii
- New York City, NY51 studii
- Boston, MA44 studii
- Seattle, WA41 studii
- Baldwin Park, CA40 studii
- Columbus, OH35 studii
- Philadelphia, PA34 studii
- Durham, NC33 studii
- Atlanta, GA31 studii
- Tampa, FL29 studii
- Chicago, IL26 studii
- Portland, OR25 studii
Alte studii în San Francisco
- Cancer de prostată45 studii
- Cancer de sân43 studii
- Cancer pulmonar cu celule non-pătrate36 studii
- Cancer (toate tipurile)35 studii
- Insuficiență cardiacă29 studii
- Cancer metastatic28 studii
- Cancer pulmonar22 studii
- Melanom22 studii
- Cancer pancreatic20 studii
- Cancer ovarian19 studii
- Cancer colorectal18 studii
- Boli cardiovasculare18 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.